Yahoo Web Search

Search results

    • Down 72%. Is Ginkgo Bioworks a Buy on the Dip?

      The Motley Fool via AOL· 6 days ago

      Disrupting the biopharmaceutical manufacturing industry could be extremely lucrative and it isn't the only way Ginkgo's cell engineering platform can earn ...